Search for a trial

Cerebrovascular effects of galantamine treatment in patients with Alzheimer's disease.

To provide an answer to the following questions: 1. In patients with AD, does treatment with a ChEI improve cerebral hemodynamics? 2. Is there less progression of cerebrovascular lesions on follow-up of AD patients receiving ChEI*s? 3. Does this…

Multicentre, Open-label, Randomised Study to Assess the Diagnostic Value of Amyloid PET
Imaging in Patients with Subjective Cognitive Decline Plus, Mild Cognitive Impairment, or Dementia
Where Alzheimer*s Disease Is in the Differential Diagnosis (Diagnostic and Patient Management
Study)

This study (AMYPAD Diagnostic and Patient Management Study) will determine in a real-life clinical setting for whom diagnostic amyloid PET imaging is appropriate, when this is best performed, and how the resulting information is influencing…

The clinical prognostic value of amyloid imaging with [18F]AV-45 in a subjects with subjective complaints

Determination of possible Alzheimer pathology in the brain and to follow-up participants over time (by means of another research protocol). In addition, its [18F]-label with a half-life of 110 minutes will enable use in hospitals without an on-site…